NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT06677151
- Status
- Recruiting
Conditions
- Sleep Apnea, Obstructive
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device — DEVICEThe NPA-OSA is a flexible, medical-grade silicone, tube-like device that is self-inserted into the user's nasopharyngeal airway through one nostril prior to sleep and worn throughout the night to reduce or alleviate snoring and obstructive sleep apnea.
Study Details
This pilot study is being done to determine if the nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device can be used in the treatment of OSA in adults. The researchers think that the NPA-OSA device will reduce the number of apneas.
Key Dates
- Start date
- Mar 7, 2025
- Status verified
- Mar 2026
- Primary completion
- Oct 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Nasopharyngeal airway deviceA nasopharyngeal airway obstructive sleep apnea ("NPA"-OSA) device will be used for one night in a sleep laboratory and 30 days at home.
Primary Outcome Measure
Change in severity of apnea hypopnea index (AHI) [ Time Frame: Baseline (day 0), 30 days ]
Central Contacts
- Zahra Nourmohammadi, PhD734 936-9816
- Louise M O'Brien, PhD734 647-9064
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Michigan Medicine | Ann Arbor | Michigan | 48109 | Zahra Nourmohammadi, PhD Louise M O'Brien, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Louise O'Brien, PhD (SUB_INVESTIGATOR) Jeff Plott, PhD (SUB_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
Related Studies
- Long-term Evaluation of a Nasopharyngeal AirwayRecruiting · University of Michigan · Ann Arbor, Michigan
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightPHASE3 · Recruiting · Eli Lilly and Company · Cullman, Alabama
- Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep ApneaPHASE2 · Recruiting · University of California, Los Angeles · Santa Monica, California
- Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) MachinePHASE1 · Recruiting · Vivek Jain · Washington D.C., District of Columbia